cromakalim has been researched along with Urinary Bladder, Neurogenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brioni, JD; Brune, ME; Coghlan, MJ; Fabiyi, AC; Gopalakrishnan, M; Lynch, JJ | 1 |
| Brown, DJ; Conway, EL; Jackman, GP; Komersova, K; Krum, H; Lim, TC; Louis, WJ; Murdoch, R; Rogerson, JW | 1 |
2 other study(ies) available for cromakalim and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
In vivo evaluation of the potency and bladder-vascular selectivity of the ATP-sensitive potassium channel openers (-)-cromakalim, ZD6169 and WAY-133537 in rats.
Topics: Amides; Animals; Benzophenones; Calcium Channels; Cromakalim; Cyclobutanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Male; Muscarinic Antagonists; Muscle Contraction; Nitriles; Rats; Rats, Sprague-Dawley; Reflex, Abnormal; Urinary Bladder; Urinary Bladder Neck Obstruction; Urinary Bladder, Neurogenic; Vasodilator Agents | 2003 |
The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions.
Topics: Adult; Analysis of Variance; Benzopyrans; Blood Pressure; Cromakalim; Humans; Infusions, Intravenous; Male; Potassium Channels; Pyrroles; Spinal Cord Injuries; Urinary Bladder, Neurogenic; Urodynamics | 1995 |